27 June 2026, Saturday
24 June 2026, Wednesday
25 June 2026, Thursday
26 June 2026, Friday
27 June 2026, Saturday
| 27 June 2026, Saturday | ||||
| BOSPHORUS HALL | TOPKAPI HALL | A2 ROOM | ||
| 07:30-08:30 | EPC Education Committe Meeting | 07:30-08:30 | ||
| 08:30-10:15 | EPC / KPBA Joint Meeting | Best Abstracts Pancreatic Cancer | 08:30-10:15 | |
| 10:15-10:45 | COFFEE BREAK & SPONSORS EXHIBITION | 10:15-10:45 | ||
| 10:45-13:00 | Hot Topics in Pancreatitis | Best Abstracts Surgery | 10:45-13:00 | |
| BOSPHORUS HALL | ||
| 08.30-10.15 | EPC/KPBA Joint Symposia Next-Generation Technologies in Pancreatology: AI, Robotics and Advanced Diagnostic Intelligence |
Chairs: Gabriele Capurso (Milan, Italy), Dong-Wan Seo (Seoul, South Korea) |
| 08.30-08.45 | AI-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes in Pancreatobiliary Tract Cancers | Young-Hoon Choi (Seoul, South Korea) |
| 08.45-09.00 | AI into Clinical Practice: Advances in PDAC Diagnosis and Treatment Decision-Making | Jung Won Chun (Seoul, South Korea) |
| 09.00-09.15 | When will AI Take Over and Make the Surgeon Unnecessary? – Future Pancreatic Robotic Surgery | Andrew Gumbs (Tiflis, Georgia) |
| 09.15-09.30 | AI-Supported Molecular Tumor Boards: Integrating Omics, Imaging and Organoid Data for PDAC Therapy Simulation | Jörg Kleeff (Halle, Germany) |
| 09.30-09.45 | AI-Guided Risk Stratification of POPF and PPH After Pancreaticoduodenectomy: From Scores to Real-Time Decision Support | Robert Grützmann (Erlangen, Germany) |
| 09.45-10.00 | Robotic and Augmented-Reality Guided Pancreatic Resection | Roberto Salvia (Verona, Italy) |
| 10.00-10.15 | Outlook EPC Meeting Stockholm 2027 | Rainer Heuchel (Stockholm, Sweden) |
| 10.15-10.45 | Coffee Break | |
| 10.45-13.00 | Hot Topics in Pancreatitis Breaking Barriers in Pancreatitis Care: Precision Medicine, Biologics and Next-Generation Interventions |
Chairs: Markus Lerch (Munich, Germany), Johanna Laukkarinen (Tampere, Finland) |
| 10.45-11.00 | Genetic and Molecular Profiling in Pancreatitis: Who Should Be Tested and How Does It Change Management? | Miklos Sahin-Toth (Los Angeles, USA) |
| 11.00-11.15 | Nutrition, Gut Microbiota and Immunomodulation in Early Acute Pancreatitis | Hannah Pauw (Amsterdam, Netherlands) |
| 11.15-11.30 | Precision Risk Prediction in Acute Pancreatitis Using AI & Radiomics: Are We Ready for Clinical Implementation | Johanna Laukkarinen (Tampere, Finnland) |
| 11.30-11.45 | From Recurrent Acute Pancreatitis to Cancer the RAP–CP–PDAC Axis: Emerging Strategies to Interrupt Progression | Vinciane Rebours (Paris, France) |
| 11.45-12.00 | Total pancreatectomy and Islet Auto Transplant: Current state and future directions: Proceedings from the Transatlantic EPC-TPIAT Symposium | Sanjay Pandanaboyana (Newcastle, UK) |
| 12.00-12.15 | Targeting the Inflammatory Cascade in Severe Acute Pancreatitis: Lessons From the Auxora CARPO Trial and Beyond? | Timothy B. Gardner (Dartmouth, USA) |
| 12.15-12.30 | Imaging Fibrosis in CP and Distinguishing AIP From Cancer: Advances in EUS Elastography & Quantitative MRI | Matteo Tacelli (Milan, Italy) |
| 12.30-12.45 | Outcome of the STELLACU Consortium | Mert Erkan (Istanbul, Turkiye) |
| 12.45-13.00 | Closing Remarks | Güralp O. Ceyhan (Istanbul, Turkiye) |
| TOPKAPI HALL |
||
| 08.30 – 10.15 | Best Abstracts Pancreatic Cancer | Chairs: Ömer Fatih Ölmez (Istanbul, Turkiye), Carmen Mota-Reyes (München, Germany) |
| 08:30-08:39 | Exploring the role of UDP-glycosyltransferase 1A1 (UGT1A1) in pancreatic adenocarcinoma patients: from polymorphisms distribution to neoplastic expression as new predictive and prognostic candidates | Marina Macchini (Milan ,Italy) |
| 08:39-08:48 | Nationwide and International Validation of the MetroPancreas Model for Predicting Futile Surgery in Anatomically Resectable Pancreatic Ductal Adenocarcinoma | Dena Akhoundzadeh (Amsterdam ,The Netherlands) |
| 08:48-08:57 | Impact of diagnosis, unmet needs and quality-of-life among informal Caregivers of people with pancreatic cancer: findings from the PAN-CARER study | Vivek Peddakota (Newcastle ,UK) |
| 08:57-09:06 | Patient-reported Anorexia/Cachexia trajectories after EUS-guided gastroenterostomy versus duodenal stenting or surgical bypass in Pancreatic Cancer: preliminary data from the multicenter, prospective GOOSE study | Rukaia Barà (Milano ,Italy) |
| 09:06-09:15 | Sequential Induction Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer for 5-year survival: A Multicenter Phase II Study | Junichiro Kawamoto (Tokyo ,Japan) |
| 09:15-09:24 | GPR160–IMPDH2 axis mediates purine metabolic reprogramming and MRC1+ macrophage polarization in pancreatic cancer | Lingdi Yin (Nanjing ,China) |
| 09:24-09:33 | The distinctive tumor ecosystem at the invasive front contributes to the immune exclusion of pancreatic ductal adenocarcinoma | Malte Torben Hermes (Heidelberg ,Germany) |
| 09:33-09:42 | Pancreatic stellate cells mediate schwann cell migration during pancreatic tumor progression in organoid models | Didem Karakas (Istanbul ,Türkiye) |
| 09:42-09:51 | β1-integrin–mediated adhesion between pancreatic cancer cells and Schwann cells drives metabolic reprogramming and neural invasion in pancreatic cancer | Rouzanna Giesert Istvánffy (Munich ,Germany) |
| 09:51-10:00 | Deciphering the Tumor-Stroma-Islet Crosstalk: ANGPTL4 as a Novel Mechanic Biomarker for Pancreatic Cancer-Associated Diabetes | Yunlong Li (Beijing ,China) |
| 10:00-10:09 | Nbs1 is essential for mitigating reactive oxygen species in pancreatic ductal adenocarcinoma | Camille Charrondière (Mainz ,Germany) |
| 10.15 – 10.45 | Coffee Break |
|
| 10.45 – 13.00 | Best Abstracts Surgery | Chairs: Ahmet Çoker (Izmir, Turkiye), Marc G. Besselink (Amsterdam, Netherlands) |
| 10:45-10:54 | ANTIthrombotic therapy and postoperative thrombotic and hemorrhagic complications after PANcreatIc surgery with vasCular resection: The ANTIPANIC Study. An International, Multicenter Study | Alessio Marchetti (Padova ,Italy) |
| 10:54-11:03 | Glucose control during 3-month treatment with a bihormonal artificial pancreas versus current diabetes care in patients after total pancreatectomy (PANORAMA): a randomised crossover trial | Charlotte Leseman (Amsterdam ,The Netherlands) |
| 11:03-11:12 | Assessment of Unallocated Pancreas Grafts from Brain-Dead Donors: Implications for Expanding the Donor Pool (EXPLORE Study) | Pegah Eslami (Heidelberg ,Germany) |
| 11:12-11:21 | Cost-effectiveness of robotic versus open pancreatoduodenectomy (DIPLOMA-2): analysis in a multicenter international randomized trial | Julia Menso (Amsterdam ,The Netherlands) |
| 11:21-11:30 | Arterial divestment compared with arterial resection in borderline resectable and locally advanced pancreatic cancer: a systematic review and meta-analysis | Eniko Toth (Budapest ,Hungary) |
| 11:30-11:39 | Clinical Significance of Textbook Oncologic Outcome After Upfront Pancreaticoduodenectomy in Elderly Patients With Resectable Pancreatic Cancer: A Multicenter Study From Japan | Masayuki Tanaka (Tokyo ,Japan) |
| 11:39-11:48 | Indications, Strategies and Perceptions of Vascular Resections in Pancreatic Cancer Surgery: Are We Doing Things the Same Way? A Pancreas 2000 International Survey | Greta Donisi (Milan ,Italy) |
| 11:48-11:57 | Comparison of indirect calorimetry measurement and weight-based formula estimate for nutritional requirements after pancreatoduodenectomy: substudy of a randomized controlled trial | Gaëtan-Romain Joliat (Lausanne ,Switzerland) |
| 11:57-12:06 | Arterial resection in pancreatic cancer surgery: the risk of hemorrhage | Filipe Castro Borges (Lisbon ,Portugal) |
| 12:06-12:15 | Textbook outcome after robotic pancreatic enucleation: Development and external validation of a composite quality metric | Marionna Cathomas (Heidelberg ,Germany) |
| 12:15-12:24 | Reducing morbidity associated with pancreatic fistula in intermediate and high risk pancreaticojejunal anastomoses with biodegradable stents | Sofoklis Mavrantonis (Guildford ,UK) |
| 12:24-12:33 | Intraoperative norepinephrine and fluid administration and their association with postoperative complications in pancreatic surgery: a retrospective cohort study | Maximilian Zauner (Hamburg ,Germany) |
| 12:33-12:42 | Long-term Outcomes of Synchronous Pancreatoduodenectomy and Liver Resection in Patients with Pancreatic Neuroendocrine Tumors with Liver Metastases | Cüneyt Kayaalp (Istanbul ,Türkiye) |
| 12:42-12:51 | Development and validation of an AI-Based Tool for Surgical Performance Assessment in Minimally Invasive Distal Pancreatectomy | Claudio Ricci (Bologna ,Italy) |
| 12:51-13:00 | Gastrointestinal symptoms after pancreatectomy in the Netherlands: a longitudinal study on their incidence and association with Health-Related Quality of Life (GO-PANC study) | Pleun Appelhof (Arnhem ,Netherlands) |
| A2 ROOM | |
| 07:30-08:30 | EPC Education Committe Meeting |
